How many insider trades does FilingIQ track for AZN?

FilingIQ tracks 8 Form 4 insider transactions for AZN (ASTRAZENECA PLC), covering filings from May 8, 2026 onwards. 3 of those are dated within the last 90 days.

Are AZN insiders net buyers or net sellers?

Across the full Form 4 history for AZN, 1 transactions (13%) were open-market purchases and 1 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AZN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is AZN in?

ASTRAZENECA PLC (AZN) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $266.15B.

AZN insider trading

NYSE Healthcare

ASTRAZENECA PLC: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

13% / 13%

Market cap

$266.15B

About ASTRAZENECA PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Company website: www.astrazeneca.com

AZN insider activity at a glance

FilingIQ tracks 8 insider transactions for AZN in filings since May 8, 2026. The most recent transaction is dated Sep 8, 2026.

Across the full history, 1 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AZN insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AZN trades on FilingIQ Raw filings on SEC EDGAR

Latest AZN Form 4 filings

Sharma Mani See Remarks

PA Sep 11, 2026

Sharma Mani SVP, Group Controller

A Aug 7, 2026

Sharma Mani See Remarks

A Jul 8, 2026

Sharma Mani See Remarks

A Jun 16, 2026

Sharma Mani See Remarks

S May 22, 2026

Sharma Mani See Remarks

A May 8, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding AZN

Evelyn Partners Group Ltd

$41.52B · 88.6% of AUM

Banque Cantonale Vaudoise

$11.31B · 1.6% of AUM

INVESTOR AB

$9.78B · 67.9% of AUM

Capital International Investors

$6.49B · 1.3% of AUM

NORGES BANK

$6.33B · 0.6% of AUM

Politicians who have traded AZN

Armstrong, Alan

U.S. Sen. · 707 trades

Frequently asked

How many insider trades does FilingIQ track for AZN?: FilingIQ tracks 8 Form 4 insider transactions for AZN (ASTRAZENECA PLC), covering filings from May 8, 2026 onwards. 3 of those are dated within the last 90 days.
Are AZN insiders net buyers or net sellers?: Across the full Form 4 history for AZN, 1 transactions (13%) were open-market purchases and 1 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AZN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is AZN in?: ASTRAZENECA PLC (AZN) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $266.15B.

Methodology & sources

Every AZN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.